MENU
+Compare
STXS
Stock ticker: ASE
AS OF
Oct 8, 02:31 PM (EDT)
Price
$3.42
Change
+$0.24 (+7.55%)
Capitalization
289.59M

STXS Stereotaxis Forecast, Technical & Fundamental Analysis

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures... Show more

STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for STXS with price predictions
Oct 07, 2025

STXS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for STXS turned positive on September 29, 2025. Looking at past instances where STXS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2025. You may want to consider a long position or call options on STXS as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STXS advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where STXS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for STXS moved out of overbought territory on October 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STXS broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: STXS's P/B Ratio (200.000) is very high in comparison to the industry average of (10.960). P/E Ratio (0.000) is within average values for comparable stocks, (55.358). STXS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.743). STXS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (8.711) is also within normal values, averaging (14.464).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

STXS is expected to report earnings to rise 20.00% to -5 cents per share on November 06

Stereotaxis STXS Stock Earnings Reports
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.02
Q1'25
Est.
$-0.07
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.03
The last earnings report on August 07 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 456.79K shares outstanding, the current market capitalization sits at 289.59M.
A.I. Advisor
published General Information

General Information

a designer of robotic cardiology instrument navigation systems

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
710 North Tucker Boulevard
Phone
+1 314 678-6100
Employees
122
Web
https://www.stereotaxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRCLF5.980.37
+6.60%
GrainCorp Ltd.
CHBJF0.84N/A
N/A
China Citic Bank Corp., Ltd.
CWBK34.57N/A
N/A
CW Bancorp
HKVTY7.33N/A
N/A
HK Electric Investments and HK Electric Investments Ltd
CBHC27.60N/A
N/A
CBC Holding Company

STXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with TWST. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-3.64%
TWST - STXS
36%
Loosely correlated
-2.29%
CERS - STXS
35%
Loosely correlated
-0.62%
RGEN - STXS
33%
Loosely correlated
-2.78%
VCYT - STXS
33%
Poorly correlated
-3.97%
SHC - STXS
32%
Poorly correlated
-0.86%
More

Groups containing STXS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-3.64%
Pharmaceuticals
category (386 stocks)
33%
Loosely correlated
+0.38%
Pharmaceuticals: Other
category (103 stocks)
29%
Poorly correlated
+0.50%